Abstract C73: Anticancer effects of a novel phosphoinositol 3-kinase inhibitor in human hepatocellular carcinoma

• Published in: Molecular cancer therapeutics Vol. 10; no. 11_Supplement; p. C73
• Main Authors: Lee, Ju-Hee, Lee, Hyunseung, Yun, Sun-Mi, Seo, Ju-Hyeon, Jung, Kyung Hee, Li, Guang-Yong, Hong, Sang-Won, Hong, Soon-Sun
• Format: Journal Article
• Language: English
• Published: 12.11.2011

Abstract The phosphatidylinositol 3-kinase (PI3K) is one of the most important regulators of cancer cell growth, survival, motility, and metabolism. As PI3K is activated in a wide variety of human malignancies, it is emerging as an attractive target for cancer treatment. Recently, we have designed a...